Abstract
Sulfated glycosaminoglycan (GAG) chains are a class of long linear polysaccharides that are covalently attached to multiple core proteins to form proteoglycans (PGs). PGs are major pericellular and extracellular matrix components that surround virtually all mammalian cell surfaces, and create conducive microenvironments for a number of essential cellular events, such as cell adhesion, cell proliferation, differentiation, and cell fate decisions. The multifunctional properties of PGs are mostly mediated by their respective GAG moieties, including chondroitin sulfate (CS), heparan sulfate (HS), and keratan sulfate (KS) chains. Structural divergence of GAG chains is enzymatically generated and strictly regulated by the corresponding biosynthetic machineries, and is the major driving force for PG functions. Recent studies have revealed indispensable roles of GAG chains in stem cell biology and technology. In this review, we summarize the current understanding of GAG chain-mediated stem cell niches, focusing primarily on structural characteristics of GAG chains and their distinct regulatory functions in stem cell maintenance and fate decisions.
Similar content being viewed by others
Abbreviations
- ß3GnT7:
-
β1,3–GlcNAc transferase-7
- β4GalT4:
-
β1,4–galactosyltransferase-4
- AP:
-
alkaline phosphatase
- BMP:
-
bone morphogenetic protein
- C4ST:
-
chondroitin 4-O-sulfotransferase
- C6ST:
-
chondroitin 6-O-sulfotransferase
- ChABC:
-
chondroitinase ABC
- ChGn:
-
chondroitin GalNAc transferase
- Chn:
-
chondroitin
- ChPF:
-
chondroitin polymerizing factor
- ChSy:
-
chondroitin synthase
- CS:
-
chondroitin sulfate
- EB:
-
embryoid body
- ESC:
-
embryonic stem cell
- EXT:
-
exostosin
- EXTL:
-
EXT-like
- FAM:
-
family with sequence similarity
- FGF:
-
fibroblast growth factor
- Fuc:
-
fucose
- GAG:
-
glycosaminoglycan
- Gal:
-
galactose
- GalNAc:
-
N-acetylgalactosamine
- GalNAc4S-6ST:
-
GalNAc 4-sulfate 6-O-sulfotransferase
- GalT-I:
-
β1,4–galactosyltransferase-I
- GalT-II:
-
β1,3–galactosyltransferase-II
- GlcA:
-
glucuronic acid
- GlcAT-I:
-
β1,3–glucuronyltransferase-I
- GLCE:
-
GlcA C5-epimerase
- GlcNAc:
-
N-acetylglucosamine
- GlcNAc6ST:
-
GlcNAc 6-O-sulfotransferase
- HS:
-
heparan sulfate
- HS2ST:
-
HS-specific uronyl 2-O-sulfotransferase
- HS3ST:
-
glucosaminyl 3-O-sulfotransferase
- HS6ST:
-
glucosaminyl 6-O-sulfotransferase
- IdoA:
-
iduronic acid
- iPS:
-
induced pluripotent stem
- KS:
-
keratan sulfate
- KSGal6ST:
-
KS Gal 6-O-sulfotransferase
- LIF:
-
leukemia inhibitory factor
- Man:
-
mannose
- NDST:
-
GlcNAc N-deacetylase/N-sulfotransferase
- NeuAc:
-
N-acetylneuraminic acid
- PDGF:
-
platelet-derived growth factor
- PE:
-
primitive endoderm
- PG:
-
proteoglycan
- PXYLP1:
-
2-O-phosphoxylose phosphatase
- RNAi:
-
RNA interference
- Ser:
-
serine
- shRNA:
-
short hairpin RNA
- UST:
-
CS-specific uronyl 2-O-sulfotransferase
- VEGF:
-
vascular endothelial growth factor
- Xyl:
-
xylose
- XYLK:
-
xylose 2-O-kinase
- XylT:
-
xylosyltransferase
References
Evans M.J., Kaufman M.H.: Establishment in culture of pluripotential cells from mouse embryos. Nature. 292(5819), 154–156 (1981)
Martin G.R.: Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U. S. A. 78(12), 7634–7638 (1981)
Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M.: Embryonic stem cell lines derived from human blastocysts. Science. 282(5391), 1145–1147 (1998)Erratum in: Science. 282(5395), 1827 (1998)
Keller G.: Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev. 19(10), 1129–1155 (2005)
Takahashi K., Yamanaka S.: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 126(4), 663–676 (2006)
Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 131(5), 861–872 (2007)
Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin I.I., Thomson J.A.: Induced pluripotent stem cell lines derived from human somatic cells. Science. 318(5858), 1917–1920 (2007)
Nadanaka S., Kitagawa H.: Heparan sulphate biosynthesis and disease. J. Biochem. 144(1), 7–14 (2008)
Mikami T., Kitagawa H.: Biosynthesis and function of chondroitin sulfate. Biochim. Biophys. Acta. 1830(10), 4719–4733 (2013)
Kitagawa H.: Using sugar remodeling to study chondroitin sulfate function. Biol. Pharm. Bull. 37(11), 1705–1712 (2014)
Sugahara K., Kitagawa H.: Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans. Curr. Opin. Struct. Biol. 10(5), 518–527 (2000)
Sugahara K., Kitagawa H.: Heparin and heparan sulfate biosynthesis. IUBMB Life. 54(4), 163–175 (2002)
Silbert J.E., Sugumaran G.: Biosynthesis of chondroitin/dermatan sulfate. IUBMB Life. 54(4), 177–186 (2002)
Kitagawa H., Uyama T., Sugahara K.: Molecular cloning and expression of a human chondroitin synthase. J. Biol. Chem. 276(42), 38721–38726 (2001)
Gotoh M., Yada T., Sato T., Akashima T., Iwasaki H., Mochizuki H., Inaba N., Togayachi A., Kudo T., Watanabe H., Kimata K., Narimatsu H.: Molecular cloning and characterization of a novel chondroitin sulfate glucuronyltransferase that transfers glucuronic acid to N-acetylgalactosamine. J. Biol. Chem. 277(41), 38179–38188 (2002)
Kitagawa H., Izumikawa T., Uyama T., Sugahara K.: Molecular cloning of a chondroitin polymerizing factor that cooperates with chondroitin synthase for chondroitin polymerization. J. Biol. Chem. 278(26), 23666–23671 (2003)
Yada T., Gotoh M., Sato T., Shionyu M., Go M., Kaseyama H., Iwasaki H., Kikuchi N., Kwon Y.D., Togayachi A., Kudo T., Watanabe H., Narimatsu H., Kimata K.: Chondroitin sulfate synthase-2. Molecular cloning and characterization of a novel human glycosyltransferase homologous to chondroitin sulfate glucuronyltransferase, which has dual enzymatic activities. J. Biol. Chem. 278(32), 30235–30247 (2003)
Yada T., Sato T., Kaseyama H., Gotoh M., Iwasaki H., Kikuchi N., Kwon Y.D., Togayachi A., Kudo T., Watanabe H., Narimatsu H., Kimata K.: Chondroitin sulfate synthase-3. Molecular cloning and characterization. J. Biol. Chem. 278(41), 39711–39725 (2003)
Izumikawa T., Uyama T., Okuura Y., Sugahara K., Kitagawa H.: Involvement of chondroitin sulfate synthase-3 (chondroitin synthase-2) in chondroitin polymerization through its interaction with chondroitin synthase-1 or chondroitin-polymerizing factor. Biochem. J. 403(3), 545–552 (2007)
Izumikawa T., Koike T., Shiozawa S., Sugahara K., Tamura J., Kitagawa H.: Identification of chondroitin sulfate glucuronyltransferase as chondroitin synthase-3 involved in chondroitin polymerization: chondroitin polymerization is achieved by multiple enzyme complexes consisting of chondroitin synthase family members. J. Biol. Chem. 283(17), 11396–11406 (2008)
Uyama T., Kitagawa H., Tamura J., Sugahara K.: Molecular cloning and expression of human chondroitin N-acetylgalactosaminyltransferase: the key enzyme for chain initiation and elongation of chondroitin/dermatan sulfate on the protein linkage region tetrasaccharide shared by heparin/heparan sulfate. J. Biol. Chem. 277(11), 8841–8846 (2002)
Gotoh M., Sato T., Akashima T., Iwasaki H., Kameyama A., Mochizuki H., Yada T., Inaba N., Zhang Y., Kikuchi N., Kwon Y.D., Togayachi A., Kudo T., Nishihara S., Watanabe H., Kimata K., Narimatsu H.: Enzymatic synthesis of chondroitin with a novel chondroitin sulfate N-acetylgalactosaminyltransferase that transfers N-acetylgalactosamine to glucuronic acid in initiation and elongation of chondroitin sulfate synthesis. J. Biol. Chem. 277(41), 38189–38196 (2002)
Sato T., Gotoh M., Kiyohara K., Akashima T., Iwasaki H., Kameyama A., Mochizuki H., Yada T., Inaba N., Togayachi A., Kudo T., Asada M., Watanabe H., Imamura T., Kimata K., Narimatsu H.: Differential roles of two N-acetylgalactosaminyltransferases, CSGalNAcT-1, and a novel enzyme, CSGalNAcT-2. Initiation and elongation in synthesis of chondroitin sulfate. J. Biol. Chem. 278(5), 3063–3071 (2003)
Uyama T., Kitagawa H., Tanaka J., Tamura J., Ogawa T., Sugahara K.: Molecular cloning and expression of a second chondroitin N-acetylgalactosaminyltransferase involved in the initiation and elongation of chondroitin/dermatan sulfate. J. Biol. Chem. 278(5), 3072–3078 (2003)
Izumikawa T., Okuura Y., Koike T., Sakoda N., Kitagawa H.: Chondroitin 4-O-sulfotransferase-1 regulates the chain length of chondroitin sulfate in co-operation with chondroitin N-acetylgalactosaminyltransferase-2. Biochem. J. 434(2), 321–331 (2011)
Izumikawa T., Koike T., Kitagawa H.: Chondroitin 4-O-sulfotransferase-2 regulates the number of chondroitin sulfate chains initiated by chondroitin N-acetylgalactosaminyltransferase-1. Biochem. J. 441(2), 697–705 (2012)
McCormick C., Duncan G., Goutsos K.T., Tufaro F.: The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc. Natl. Acad. Sci. U. S. A. 97(2), 668–673 (2000)
Kim B.T., Kitagawa H., Tanaka J., Tamura J., Sugahara K.: In vitro heparan sulfate polymerization: crucial roles of core protein moieties of primer substrates in addition to the EXT1-EXT2 interaction. J. Biol. Chem. 278(43), 41618–41623 (2003)
Kusche-Gullberg M., Kjellén L.: Sulfotransferases in glycosaminoglycan biosynthesis. Sulfotransferases in glycosaminoglycan biosynthesis. Curr. Opin. Struct. Biol. 13(5), 605–611 (2003)
Gulberti S., Lattard V., Fondeur M., Jacquinet J.C., Mulliert G., Netter P., Magdalou J., Ouzzine M., Fournel-Gigleux S.: Phosphorylation and sulfation of oligosaccharide substrates critically influence the activity of human beta1,4-galactosyltransferase 7 (GalT-I) and beta1,3-glucuronosyltransferase I (GlcAT-I) involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans. J. Biol. Chem. 280(2), 1417–1425 (2005)
Tone Y., Pedersen L.C., Yamamoto T., Izumikawa T., Kitagawa H., Nishihara J., Tamura J., Negishi M., Sugahara K.: 2-o-phosphorylation of xylose and 6-o-sulfation of galactose in the protein linkage region of glycosaminoglycans influence the glucuronyltransferase-I activity involved in the linkage region synthesis. J. Biol. Chem. 283(24), 16801–16807 (2008)
Wen J., Xiao J., Rahdar M., Choudhury B.P., Cui J., Taylor G.S., Esko J.D., Dixon J.E.: Xylose phosphorylation functions as a molecular switch to regulate proteoglycan biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 111(44), 15723–15728 (2014)
Koike T., Izumikawa T., Tamura J., Kitagawa H.: FAM20B is a kinase that phosphorylates xylose in the glycosaminoglycan-protein linkage region. Biochem. J. 421(2), 157–162 (2009)
Koike T., Izumikawa T., Sato B., Kitagawa H.: Identification of phosphatase that dephosphorylates xylose in the glycosaminoglycan-protein linkage region of proteoglycans. J. Biol. Chem. 289(10), 6695–6708 (2014)
Izumikawa T., Sato B., Mikami T., Tamura J., Igarashi M., Kitagawa H.: GlcUAβ1-3Galβ1-3Galβ1-4Xyl(2-O-phosphate) is the preferred substrate for chondroitin N-acetylgalactosaminyltransferase-1. J. Biol. Chem. 290(9), 5438–5448 (2015)
Nadanaka S., Zhou S., Kagiyama S., Shoji N., Sugahara K., Sugihara K., Asano M., Kitagawa H.: EXTL2, a member of the EXT family of tumor suppressors, controls glycosaminoglycan biosynthesis in a xylose kinase-dependent manner. J. Biol. Chem. 288(13), 9321–9333 (2013)
Funderburgh J.L.: Keratan sulfate: structure, biosynthesis, and function. Glycobiology. 10(10), 951–958 (2000)
Funderburgh J.L.: Keratan sulfate biosynthesis. IUBMB Life. 54(4), 187–194 (2002)
Kawabe K., Tateyama D., Toyoda H., Kawasaki N., Hashii N., Nakao H., Matsumoto S., Nonaka M., Matsumura H., Hirose Y., Morita A., Katayama M., Sakuma M., Kawasaki N., Furue M.K., Kawasaki T.: A novel antibody for human induced pluripotent stem cells and embryonic stem cells recognizes a type of keratan sulfate lacking oversulfated structures. Glycobiology. 23(3), 322–336 (2013)
Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P., Guenther M.G., Kumar R.M., Murray H.L., Jenner R.G., Gifford D.K., Melton D.A., Jaenisch R., Young R.A.: Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 122(6), 947–956 (2005)
Williams R.L., Hilton D.J., Pease S., Willson T.A., Stewart C.L., Gearing D.P., Wagner E.F., Metcalf D., Nicola N.A., Gough N.M.: Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature. 336(6200), 684–687 (1988)
Smith A.G., Heath J.K., Donaldson D.D., Wong G.G., Moreau J., Stahl M., Rogers D.: Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature. 336(6200), 688–690 (1988)
Okita K., Yamanaka S.: Intracellular signaling pathways regulating pluripotency of embryonic stem cells. Curr. Stem Cell Res. Ther. 1(1), 103–111 (2006)
Xu R.H., Peck R.M., Li D.S., Feng X., Ludwig T., Thomson J.A.: Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat. Methods. 2(3), 185–190 (2005)
Levenstein M.E., Ludwig T.E., Xu R.H., Llanas R.A., VanDenHeuvel-Kramer K., Manning D., Thomson J.A.: Basic fibroblast growth factor support of human embryonic stem cell self-renewal. Stem Cells. 24(3), 568–574 (2006)
Lin X., Wei G., Shi Z., Dryer L., Esko J.D., Wells D.E., Matzuk M.M.: Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev. Biol. 224(2), 299–311 (2000)
Nairn A.V., Kinoshita-Toyoda A., Toyoda H., Xie J., Harris K., Dalton S., Kulik M., Pierce J.M., Toida T., Moremen K.W., Linhardt R.J.: Glycomics of proteoglycan biosynthesis in murine embryonic stem cell differentiation. J. Proteome Res. 6(11), 4374–4387 (2007)
Izumikawa T., Sato B., Kitagawa H.: Chondroitin sulfate is indispensable for pluripotency and differentiation of mouse embryonic stem cells. Sci. Rep. 4, 3701 (2014)
Johnson C.E., Crawford B.E., Stavridis M., Ten Dam G., Wat A.L., Rushton G., Ward C.M., Wilson V., van Kuppevelt T.H., Esko J.D., Smith A., Gallagher J.T., Merry C.L.: Essential alterations of heparan sulfate during the differentiation of embryonic stem cells to Sox1-enhanced green fluorescent protein-expressing neural progenitor cells. Stem Cells. 25(8), 1913–1923 (2007)Erratum in: Stem Cells. 25(9), 2389 (2007)
Gasimli L., Hickey A.M., Yang B., Li G., dela Rosa M., Nairn A.V., Kulik M.J., Dordick J.S., Moremen K.W., Dalton S., Linhardt R.J.: Changes in glycosaminoglycan structure on differentiation of human embryonic stem cells towards mesoderm and endoderm lineages. Biochim. Biophys. Acta. 1840(6), 1993–2003 (2014)
Kraushaar D.C., Yamaguchi Y., Wang L.: Heparan sulfate is required for embryonic stem cells to exit from self-renewal. J. Biol. Chem. 285(8), 5907–5916 (2010) Erratum in: J. Biol. Chem. 290(38), 23023 (2015)
Holley R.J., Pickford C.E., Rushton G., Lacaud G., Gallagher J.T., Kouskoff V., Merry C.L.: Influencing hematopoietic differentiation of mouse embryonic stem cells using soluble heparin and heparan sulfate saccharides. J. Biol. Chem. 286(8), 6241–6252 (2011)
Holmborn K., Ledin J., Smeds E., Eriksson I., Kusche-Gullberg M., Kjellén L.: Heparan sulfate synthesized by mouse embryonic stem cells deficient in NDST1 and NDST2 is 6-O-sulfated but contains no N-sulfate groups. J. Biol. Chem. 279(41), 42355–42358 (2004)
Izumikawa T., Kanagawa N., Watamoto Y., Okada M., Saeki M., Sakano M., Sugahara K., Sugihara K., Asano M., Kitagawa H.: Impairment of embryonic cell division and glycosaminoglycan biosynthesis in glucuronyltransferase-I-deficient mice. J. Biol. Chem. 285(16), 12190–12196 (2010)
Kitagawa H., Tone Y., Tamura J., Neumann K.W., Ogawa T., Oka S., Kawasaki T., Sugahara K.: Molecular cloning and expression of glucuronyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans. J. Biol. Chem. 273(12), 6615–6618 (1998)
Wei G., Bai X., Sarkar A.K., Esko J.D.: Formation of HNK-1 determinants and the glycosaminoglycan tetrasaccharide linkage region by UDP-GlcUA:galactose beta1, 3-glucuronosyltransferases. J. Biol. Chem. 274(12), 7857–7864 (1999)
Lin X.: Functions of heparan sulfate proteoglycans in cell signaling during development. Development. 131(24), 6009–6021 (2004)
Kreuger J., Spillmann D., Li J.P., Lindahl U.: Interactions between heparan sulfate and proteins: the concept of specificity. J. Cell Biol. 174(3), 323–327 (2006)
Bishop J.R., Schuksz M., Esko J.D.: Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature. 446(7139), 1030–1037 (2007)
Ying Q.L., Nichols J., Chambers I., Smith A.: BMP induction of id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell. 115(3), 281–292 (2003)
Hao J., Li T.G., Qi X., Zhao D.F., Zhao G.Q.: WNT/beta-catenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells. Dev. Biol. 290(1), 81–91 (2006)
Cole M.F., Johnstone S.E., Newman J.J., Kagey M.H., Young R.A.: Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes Dev. 22(6), 746–755 (2008)
Pickford C.E., Holley R.J., Rushton G., Stavridis M.P., Ward C.M., Merry C.L.: Specific glycosaminoglycans modulate neural specification of mouse embryonic stem cells. Stem Cells. 29(4), 629–640 (2010)
Lanner F., Lee K.L., Sohl M., Holmborn K., Yang H., Wilbertz J., Poellinger L., Rossant J., Farnebo F.: Heparan sulfation-dependent fibroblast growth factor signaling maintains embryonic stem cells primed for differentiation in a heterogeneous state. Stem Cells. 28(2), 191–200 (2010)
Sasaki N., Okishio K., Ui-Tei K., Saigo K., Kinoshita-Toyoda A., Toyoda H., Nishimura T., Suda Y., Hayasaka M., Hanaoka K., Hitoshi S., Ikenaka K., Nishihara S.: Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells. J. Biol. Chem. 2283(6), 3594–3606 (2008)
Kang M., Piliszek A., Artus J., Hadjantonakis A.K.: FGF4 is required for lineage restriction and salt-and-pepper distribution of primitive endoderm factors but not their initial expression in the mouse. Development. 140(2), 267–279 (2013)
Mikami, T., Kitagawa, H. (2014). Glycosaminoglycans: their modes of action for a possible new avenue for therapeutic intervention. In: Taniguchi, N., Endo, T., Hart, G.W., Seeberger, P.H., Wong, C.H., (eds) Glycoscience: Biology and Medicine, pp. 511–517. Springer, Tokyo
Mikami T., Yasunaga D., Kitagawa H.: Contactin-1 is a functional receptor for neuroregulatory chondroitin sulfate-E. J. Biol. Chem. 284(7), 4494–4499 (2009)
Shen Y., Tenney A.P., Busch S.A., Horn K.P., Cuascut F.X., Liu K., He Z., Silver J., Flanagan J.G.: PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science. 326(5952), 592–596 (2009)
Coles C.H., Shen Y., Tenney A.P., Siebold C., Sutton G.C., Lu W., Gallagher J.T., Jones E.Y., Flanagan J.G., Aricescu A.R.: Proteoglycan-specific molecular switch for RPTPσ clustering and neuronal extension. Science. 332(6028), 484–488 (2011)
Fisher D., Xing B., Dill J., Li H., Hoang H.H., Zhao Z., Yang X.L., Bachoo R., Cannon S., Longo F.M., Sheng M., Silver J., Li S.: Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors. J. Neurosci. 31(40), 14051–14066 (2011)
Dickendesher T.L., Baldwin K.T., Mironova Y.A., Koriyama Y., Raiker S.J., Askew K.L., Wood A., Geoffroy C.G., Zheng B., Liepmann C.D., Katagiri Y., Benowitz L.I., Geller H.M., Giger R.J.: NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans. Nat. Neurosci. 15(5), 703–712 (2012)
Koike T., Izumikawa T., Tamura J., Kitagawa H.: Chondroitin sulfate-E fine-tunes osteoblast differentiation via ERK1/2, Smad3 and Smad1/5/8 signaling by binding to N-cadherin and cadherin-11. Biochem. Biophys. Res. Commun. 420(3), 523–529 (2012)
Koike T., Mikami T., Shida M., Habuchi O., Kitagawa H.: Chondroitin sulfate-E mediates estrogen-induced osteoanabolism. Sci. Rep. 5, 8994 (2015)
Soncin F., Mohamet L., Eckardt D., Ritson S., Eastham A.M., Bobola N., Russell A., Davies S., Kemler R., Merry C.L., Ward C.M.: Abrogation of E-cadherin-mediated cell-cell contact in mouse embryonic stem cells results in reversible LIF-independent self-renewal. Stem Cells. 27(9), 2069–2080 (2009)
Chen T., Yuan D., Wei B., Jiang J., Kang J., Ling K., Gu Y., Li J., Xiao L., Pei G.: E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation. Stem Cells. 28(8), 1315–1325 (2010)
Spencer H.L., Eastham A.M., Merry C.L., Southgate T.D., Perez-Campo F., Soncin F., Ritson S., Kemler R., Stern P.L., Ward C.M.: E-cadherin inhibits cell surface localization of the pro-migratory 5 T4 oncofetal antigen in mouse embryonic stem cells. Mol. Biol. Cell. 18(8), 2838–2851 (2007)
Li R., Liang J., Ni S., Zhou T., Qing X., Li H., He W., Chen J., Li F., Zhuang Q., Qin B., Xu J., Li W., Yang J., Gan Y., Qin D., Feng S., Song H., Yang D., Zhang B., Zeng L., Lai L., Esteban M.A., Pei D.: A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell. 7(1), 51–63 (2010)
Redmer T., Diecke S., Grigoryan T., Quiroga-Negreira A., Birchmeier W., Besser D.: E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming. EMBO Rep. 12(7), 720–726 (2011)
Kunath T., Saba-El-Leil M.K., Almousailleakh M., Wray J., Meloche S., Smith A.: FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development. 134(16), 2895–2902 (2007)
Kraushaar D.C., Rai S., Condac E., Nairn A., Zhang S., Yamaguchi Y., Moremen K., Dalton S., Wang L.: Heparan sulfate facilitates FGF and BMP signaling to drive mesoderm differentiation of mouse embryonic stem cells. J. Biol. Chem. 287(27), 22691–22700 (2012)
Tanaka S.S., Kojima Y., Yamaguchi Y.L., Nishinakamura R., Tam P.P.: Impact of WNT signaling on tissue lineage differentiation in the early mouse embryo. Develop. Growth Differ. 53(7), 843–856 (2011)
Jakobsson L., Kreuger J., Holmborn K., Lundin L., Eriksson I., Kjellén L., Claesson-Welsh L.: Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev. Cell. 10(5), 625–634 (2006)
Le Jan S., Hayashi M., Kasza Z., Eriksson I., Bishop J.R., Weibrecht I., Heldin J., Holmborn K., Jakobsson L., Söderberg O., Spillmann D., Esko J.D., Claesson-Welsh L., Kjellén L., Kreuger J.: Functional overlap between chondroitin and heparan sulfate proteoglycans during VEGF-induced sprouting angiogenesis. Arterioscler. Thromb. Vasc. Biol. 32(5), 1255–1263 (2012)
Forsberg M., Holmborn K., Kundu S., Dagälv A., Kjellén L., Forsberg-Nilsson K.: Undersulfation of heparan sulfate restricts differentiation potential of mouse embryonic stem cells. J. Biol. Chem. 287(14), 10853–10862 (2012)
Acknowledgments
This work was supported in part by Grants-in-aid for Scientific Research (C) #16K07306 (to T. M.), and for Scientific Research (B) #16H05088 (to H. K.), and the Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016 (to H. K.) from Ministry of Education, Culture, Sports, Science & Technology, Japan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Mikami, T., Kitagawa, H. Sulfated glycosaminoglycans: their distinct roles in stem cell biology. Glycoconj J 34, 725–735 (2017). https://doi.org/10.1007/s10719-016-9732-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-016-9732-9